Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	112.95	120.26	109.97	68.4	47.98	31
Short-Term Investments	392.73	368.49	264.92	338.77	394.44	265.2
Cash & Short-Term Investments	505.68	488.74	374.88	407.17	442.42	296.2
Cash Growth	-8.05%	30.37%	-7.93%	-7.97%	49.36%	222.11%
Accounts Receivable	-	0.95	18.76	2.54	0.14	1.43
Receivables	-	0.95	18.76	2.54	0.14	1.43
Prepaid Expenses	22.62	20.58	11.67	9.71	8.72	4.7
Total Current Assets	528.3	510.27	405.32	419.42	451.27	302.34
Property, Plant & Equipment	88.08	97.86	101.08	22.24	21.31	20.69
Long-Term Investments	473.06	362.16	61.43	152.33	125.19	162.53
Other Long-Term Assets	12.62	7.74	7.93	9.15	8.14	1.62
Total Assets	1,102	978.04	575.76	603.13	605.91	487.18
Accounts Payable	5.51	5.99	7.08	4.34	4.01	4.37
Accrued Expenses	28.64	34.87	33.86	27.5	22.97	10.33
Current Portion of Leases	13.74	13.11	6.35	3.94	3.6	3.26
Current Unearned Revenue	23.28	13.58	37.88	35.26	61.74	92.55
Other Current Liabilities	0.41	0.22	0.52	0.3	0.23	0.11
Total Current Liabilities	71.58	67.77	85.69	71.34	92.54	110.62
Long-Term Leases	70.25	74.65	78.33	13.39	14.36	14.73
Long-Term Unearned Revenue	13.96	-	16.77	28	39.3	77.84
Other Long-Term Liabilities	-	-	-	0.25	0.07	0.1
Total Liabilities	155.79	142.42	180.79	112.98	146.27	203.29
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,924	1,592	926.27	878.88	689.28	412.78
Retained Earnings	-978.98	-754.61	-530.75	-383.79	-228.98	-128.77
Comprehensive Income & Other	1.5	-1.49	-0.55	-4.95	-0.66	-0.13
Total Common Equity	946.26	835.62	394.97	490.15	459.64	283.89
Shareholders' Equity	946.26	835.62	394.97	490.15	459.64	283.89
Total Liabilities & Equity	1,102	978.04	575.76	603.13	605.91	487.18
Total Debt	84	87.76	84.67	17.34	17.96	17.99
Net Cash (Debt)	894.74	763.14	351.64	542.16	549.64	440.74
Net Cash Growth	8.75%	117.02%	-35.14%	-1.36%	24.71%	522.83%
Net Cash Per Share	10.91	10.17	6.02	10.05	11.45	25.40
Filing Date Shares Outstanding	71.95	64.94	61.11	55.18	51.67	44.81
Total Common Shares Outstanding	71.74	64.89	55.59	55.04	51.5	44.48
Working Capital	456.72	442.5	319.63	348.07	358.73	191.72
Book Value Per Share	13.19	12.88	7.11	8.91	8.93	6.38
Tangible Book Value	946.26	835.62	394.97	490.15	459.64	283.89
Tangible Book Value Per Share	13.19	12.88	7.11	8.91	8.93	6.38
Machinery	15.77	14.75	6.74	5.8	4.02	2.59
Leasehold Improvements	42.91	44.01	7.8	7.8	7.74	7.6

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q